1. Home
  2. CNTA vs SIMO Comparison

CNTA vs SIMO Comparison

Compare CNTA & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • SIMO
  • Stock Information
  • Founded
  • CNTA 2020
  • SIMO 1995
  • Country
  • CNTA United Kingdom
  • SIMO Hong Kong
  • Employees
  • CNTA N/A
  • SIMO N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • SIMO Semiconductors
  • Sector
  • CNTA Health Care
  • SIMO Technology
  • Exchange
  • CNTA Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • CNTA 1.6B
  • SIMO 2.4B
  • IPO Year
  • CNTA 2021
  • SIMO 2005
  • Fundamental
  • Price
  • CNTA $14.07
  • SIMO $74.81
  • Analyst Decision
  • CNTA Strong Buy
  • SIMO Strong Buy
  • Analyst Count
  • CNTA 10
  • SIMO 8
  • Target Price
  • CNTA $28.78
  • SIMO $80.63
  • AVG Volume (30 Days)
  • CNTA 1.2M
  • SIMO 342.8K
  • Earning Date
  • CNTA 08-12-2025
  • SIMO 07-31-2025
  • Dividend Yield
  • CNTA N/A
  • SIMO 2.67%
  • EPS Growth
  • CNTA N/A
  • SIMO 59.19
  • EPS
  • CNTA N/A
  • SIMO 2.80
  • Revenue
  • CNTA $15,000,000.00
  • SIMO $780,733,000.00
  • Revenue This Year
  • CNTA N/A
  • SIMO $2.23
  • Revenue Next Year
  • CNTA N/A
  • SIMO $13.23
  • P/E Ratio
  • CNTA N/A
  • SIMO $26.75
  • Revenue Growth
  • CNTA 118.88
  • SIMO 10.84
  • 52 Week Low
  • CNTA $8.46
  • SIMO $37.21
  • 52 Week High
  • CNTA $19.09
  • SIMO $85.00
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 60.47
  • SIMO 67.32
  • Support Level
  • CNTA $12.74
  • SIMO $73.09
  • Resistance Level
  • CNTA $14.27
  • SIMO $76.77
  • Average True Range (ATR)
  • CNTA 0.66
  • SIMO 2.07
  • MACD
  • CNTA 0.12
  • SIMO -0.09
  • Stochastic Oscillator
  • CNTA 85.57
  • SIMO 72.34

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: